Notably, among the 13 SSc patients who were double negative for ATA and ACA, 6 tested positive for anti-PRMT5 antibodies, suggesting potential additional diagnostic value of anti-PRMT5 in SSc (Supplementary Table 2). The gene discussed is PRMT5; the disease is systemic sclerosis.